NCT06984250

Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer

Hybrid Techniques Combining Hypofractionated Whole Breast Radiotherapy With Concomitant Tumor Bed Boost in Patients With Breast Cancer

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 315 (estimated)
• Sponsor: National Taiwan University Hospital · Academic / Other
• Sex: Female
• Age: 20 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

Hypofractionated breast radiotherapy with concomitant tumor bed boost for early breast cancer or ductal breast carcinoma in situ after partial mastectomy

Conditions

• Early Breast Cancer
• Ductal Breast Carcinoma In Situ

Interventions

Type	Name	Description
RADIATION	Hypofractionated Radiation Therapy	Hypofractionated breast radiotherapy (HFRT) with hybrid techniques combining field-in-field intensity-modulated RT (FIF-IMRT) to the whole breast with inverse-IMRT for concomitant boost

Timeline

• Start date: 2025-02-06
• Primary completion: 2027-02-28
• Completion: 2030-02-28
• First posted: 2025-05-22
• Last updated: 2025-05-22

Locations

2 sites across 1 country: Taiwan

Regulatory

• FDA-regulated device study